| scholarly article | Q13442814 |
| P2093 | author name string | J D Knudsen | |
| K Fuursted | |||
| R H Jensen | |||
| M C Arendrup | |||
| S J Howard | |||
| H K Johansen | |||
| B Gahrn-Hansen | |||
| K L Mortensen | |||
| P2860 | cites work | Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome | Q24811601 |
| Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference | Q28207287 | ||
| Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease | Q28251330 | ||
| Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome | Q28264458 | ||
| National surveillance of fungemia in Denmark (2004 to 2009) | Q28743556 | ||
| Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism | Q30853962 | ||
| Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus | Q30984430 | ||
| Aspergillosis case-fatality rate: systematic review of the literature | Q31918085 | ||
| Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. | Q33183542 | ||
| Invasive aspergillosis in transplant recipients | Q33589376 | ||
| Critical evaluation of 4-week incubation for fungal cultures: is the fourth week useful? | Q33686511 | ||
| Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study | Q33800526 | ||
| Factors associated with mortality in transplant patients with invasive aspergillosis | Q33867013 | ||
| Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review | Q34230722 | ||
| Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. | Q34455633 | ||
| Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience | Q34455699 | ||
| The invasive and saprophytic syndromes due to Aspergillus spp. | Q36235153 | ||
| Laboratory diagnosis of invasive aspergillosis. | Q36267587 | ||
| Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality | Q36715387 | ||
| Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ | Q37164067 | ||
| Significance of Aspergillus species isolated from respiratory secretions in the diagnosis of invasive pulmonary aspergillosis | Q37324068 | ||
| Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods | Q37374949 | ||
| Noninvasive pulmonary Aspergillus infections | Q37449868 | ||
| Azole-resistance in Aspergillus: proposed nomenclature and breakpoints | Q37625111 | ||
| Clinical risk factors for invasive aspergillosis | Q37780754 | ||
| Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus. | Q39687164 | ||
| Duration of incubation of fungal cultures | Q40011000 | ||
| Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. | Q40524039 | ||
| Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients | Q41998776 | ||
| Aspergillus section Fumigati: antifungal susceptibility patterns and sequence-based identification | Q42112017 | ||
| Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document) | Q42428186 | ||
| Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure | Q42555868 | ||
| Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. | Q42930104 | ||
| The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis | Q44060978 | ||
| Factors associated with overall and attributable mortality in invasive aspergillosis | Q44431234 | ||
| Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination | Q44484728 | ||
| Aspergillus infection in lung transplant patients: incidence and prognosis | Q44495078 | ||
| Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp. | Q46444751 | ||
| EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts | Q46812076 | ||
| Clinical significance of lower respiratory tract Aspergillus culture in elderly hospitalized patients | Q47981565 | ||
| The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. | Q51191763 | ||
| Diagnosis of pulmonary infection caused by Aspergillus: usefulness of respiratory cultures. | Q51197961 | ||
| Laboratory detection and identification of Aspergillus species by microscopic observation and culture: the traditional approach. | Q51369487 | ||
| Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. | Q51700168 | ||
| EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia–forming moulds | Q56837279 | ||
| Risk Factors for Invasive Aspergillosis in Solid-Organ Transplant Recipients: A Case-Control Study | Q57569335 | ||
| Allergic Bronchopulmonary Aspergillosis | Q57749833 | ||
| Respiratory tract Aspergillus: clinical significance | Q71134148 | ||
| Diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis | Q73497580 | ||
| Invasive aspergillosis | Q74492548 | ||
| The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study | Q80050239 | ||
| Invasive aspergillosis in critically ill patients without malignancy | Q80269940 | ||
| Invasive aspergillosis in solid organ transplant recipients | Q82491550 | ||
| P433 | issue | 11 | |
| P304 | page(s) | 1355-1363 | |
| P577 | publication date | 2011-05-04 | |
| P1433 | published in | European Journal of Clinical Microbiology & Infectious Diseases | Q15754378 |
| P1476 | title | A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility. | |
| P478 | volume | 30 |
| Q30849702 | A Case Report on Aspergillus lentulus Pneumonia. |
| Q52936136 | Analysis of the clinical features of invasive bronchopulmonary aspergillosis. |
| Q35666518 | Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan |
| Q39796605 | Antifungal susceptibility of 175 Aspergillus isolates from various clinical and environmental sources |
| Q44157648 | Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles |
| Q30234423 | Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways |
| Q44420540 | Assessment of the significance of respiratory culture of Aspergillus in the non-neutropenic patient. A critique of published diagnostic criteria. |
| Q99237703 | Azole-Resistant Aspergillus fumigatus Among Danish Cystic Fibrosis Patients: Increasing Prevalence and Dominance of TR34/L98H |
| Q57650487 | Azole-Resistant Invasive Aspergillosis: Relationship to Agriculture |
| Q24605723 | Discovery of a sexual cycle in Aspergillus lentulus, a close relative of A. fumigatus |
| Q41595745 | Early invasive pulmonary aspergillosis in a kidney transplant recipient caused by Aspergillus lentulus: first Brazilian report. |
| Q28068091 | Epidemiological and Genomic Landscape of Azole Resistance Mechanisms in Aspergillus Fungi |
| Q47558222 | Fungi in Bronchiectasis: A Concise Review |
| Q47573607 | Fungus-Specific CD4 T Cells as Specific Sensors for Identification of Pulmonary Fungal Infections. |
| Q46910359 | Increased prevalence and altered species composition of filamentous fungi in respiratory specimens from cystic fibrosis patients |
| Q37026702 | Is azole resistance in Aspergillus fumigatus a problem in Spain? |
| Q37287794 | Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome |
| Q42214481 | Molecular screening of 246 Portuguese Aspergillus isolates among different clinical and environmental sources |
| Q59089617 | New Respirable and Fast Dissolving Itraconazole Dry Powder Composition for the Treatment of Invasive Pulmonary Aspergillosis |
| Q39221749 | One-health pathogens in the Aspergillus viridinutans complex. |
| Q34532546 | Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America |
| Q97427835 | Pulmonary Aspergillosis: An Evolving Challenge for Diagnosis and Treatment |
| Q40779654 | Recurrent prosthetic valve endocarditis caused by Aspergillus delacroxii (formerly Aspergillus nidulans var. echinulatus). |
| Q28730299 | The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management |
| Q40451819 | The burden of fungal disease in Denmark. |
| Q54321109 | The performance of real-time PCR, galactomannan, and fungal culture in the diagnosis of invasive aspergillosis in ventilated patients with chronic obstructive pulmonary disease (COPD). |
| Q36603083 | Tracheobronchial mycosis in a retrospective case-series study of five status asthmaticus patients |
| Q93376926 | Utility of serum galactomannan antigen testing combined with chest computed tomography for early diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies with febrile neutropenia after antifungal drug treatment |
Search more.